174 related articles for article (PubMed ID: 22864358)
1. miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation.
Lin X; Rice KL; Buzzai M; Hexner E; Costa FF; Kilpivaara O; Mullally A; Soares MB; Ebert BL; Levine R; Licht JD
Leukemia; 2013 Feb; 27(2):344-52. PubMed ID: 22864358
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm.
Yin LH; Zheng XQ; Li HY; Bi LX; Shi YF; Ye AF; Wu JB; Gao SM
Leuk Res; 2015 Apr; 39(4):471-8. PubMed ID: 25666256
[TBL] [Abstract][Full Text] [Related]
3. Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia.
Rinaldi CR; Rinaldi P; Alagia A; Gemei M; Esposito N; Formiggini F; Martinelli V; Senyuk V; Nucifora G; Pane F
Blood; 2010 Dec; 116(26):6023-6. PubMed ID: 20861460
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F.
Berkofsky-Fessler W; Buzzai M; Kim MK; Fruchtman S; Najfeld V; Min DJ; Costa FF; Bischof JM; Soares MB; McConnell MJ; Zhang W; Levine R; Gilliland DG; Calogero R; Licht JD
Clin Cancer Res; 2010 Sep; 16(17):4339-52. PubMed ID: 20601445
[TBL] [Abstract][Full Text] [Related]
5. IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.
de Melo Campos P; Machado-Neto JA; Eide CA; Savage SL; Scopim-Ribeiro R; da Silva Souza Duarte A; Favaro P; Lorand-Metze I; Costa FF; Tognon CE; Druker BJ; Olalla Saad ST; Traina F
Oncotarget; 2016 Feb; 7(6):6948-59. PubMed ID: 26755644
[TBL] [Abstract][Full Text] [Related]
6. Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.
Baran-Marszak F; Magdoud H; Desterke C; Alvarado A; Roger C; Harel S; Mazoyer E; Cassinat B; Chevret S; Tonetti C; Giraudier S; Fenaux P; Cymbalista F; Varin-Blank N; Le Bousse-Kerdilès MC; Kiladjian JJ; Velazquez L
Blood; 2010 Dec; 116(26):5961-71. PubMed ID: 20870899
[TBL] [Abstract][Full Text] [Related]
7. Methylated alteration of SHP1 complements mutation of JAK2 tyrosine kinase in patients with myeloproliferative neoplasm.
Yang JJ; Chen H; Zheng XQ; Li HY; Wu JB; Tang LY; Gao SM
Asian Pac J Cancer Prev; 2015; 16(6):2219-25. PubMed ID: 25824741
[TBL] [Abstract][Full Text] [Related]
8. miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets.
Girardot M; Pecquet C; Boukour S; Knoops L; Ferrant A; Vainchenker W; Giraudier S; Constantinescu SN
Blood; 2010 Jul; 116(3):437-45. PubMed ID: 20445018
[TBL] [Abstract][Full Text] [Related]
9. Identification of gene networks associated with erythroid differentiation.
Peller S; Tabach Y; Rotschild M; Garach-Joshua O; Cohen Y; Goldfinger N; Rotter V
Blood Cells Mol Dis; 2009; 43(1):74-80. PubMed ID: 19329339
[TBL] [Abstract][Full Text] [Related]
10. Ph(-) myeloproliferative neoplasm red blood cells display deregulation of IQGAP1-Rho GTPase signaling depending on CALR/JAK2 status.
Socoro-Yuste N; Dagher MC; Gonzalez De Peredo A; Mondet J; Zaccaria A; Roux Dalvai F; Plo I; Cahn JY; Mossuz P
Biochim Biophys Acta; 2016 Nov; 1863(11):2758-2765. PubMed ID: 27566291
[TBL] [Abstract][Full Text] [Related]
11. Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation
Woods B; Chen W; Chiu S; Marinaccio C; Fu C; Gu L; Bulic M; Yang Q; Zouak A; Jia S; Suraneni PK; Xu K; Levine RL; Crispino JD; Wen QJ
Clin Cancer Res; 2019 Oct; 25(19):5901-5912. PubMed ID: 31217200
[TBL] [Abstract][Full Text] [Related]
12. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis.
Bruchova H; Yoon D; Agarwal AM; Mendell J; Prchal JT
Exp Hematol; 2007 Nov; 35(11):1657-67. PubMed ID: 17976518
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera.
Guglielmelli P; Tozzi L; Bogani C; Iacobucci I; Ponziani V; Martinelli G; Bosi A; Vannucchi AM;
Blood; 2011 Jun; 117(25):6923-7. PubMed ID: 21527532
[TBL] [Abstract][Full Text] [Related]
14. mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms.
Bogani C; Bartalucci N; Martinelli S; Tozzi L; Guglielmelli P; Bosi A; Vannucchi AM;
PLoS One; 2013; 8(1):e54826. PubMed ID: 23382981
[TBL] [Abstract][Full Text] [Related]
15. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
Farhadi E; Zaker F; Safa M; Rezvani MR
Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
[TBL] [Abstract][Full Text] [Related]
16. miR-150 inhibits terminal erythroid proliferation and differentiation.
Sun Z; Wang Y; Han X; Zhao X; Peng Y; Li Y; Peng M; Song J; Wu K; Sun S; Zhou W; Qi B; Zhou C; Chen H; An X; Liu J
Oncotarget; 2015 Dec; 6(40):43033-47. PubMed ID: 26543232
[TBL] [Abstract][Full Text] [Related]
17. MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms.
Dumas PY; Mansier O; Prouzet-Mauleon V; Koya J; Villacreces A; Brunet de la Grange P; Luque Paz D; Bidet A; Pasquet JM; Praloran V; Salin F; Kurokawa M; Mahon FX; Cardinaud B; Lippert E
BMC Cancer; 2018 Nov; 18(1):1098. PubMed ID: 30419846
[TBL] [Abstract][Full Text] [Related]
18. Effect of hypoxia on HIF-1α and NOS3 expressions in CD34
Şoroğlu CV; Uslu-Bıçak İ; Toprak SF; Yavuz AS; Sözer S
Adv Med Sci; 2023 Sep; 68(2):169-175. PubMed ID: 37075583
[TBL] [Abstract][Full Text] [Related]
19. Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms.
Benati M; Montagnana M; Danese E; De Matteis G; Veneri D; Paviati E; Guidi GC
Clin Chem Lab Med; 2015 Jun; 53(7):1005-11. PubMed ID: 25527813
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis.
Choong ML; Yang HH; McNiece I
Exp Hematol; 2007 Apr; 35(4):551-64. PubMed ID: 17379065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
